Billionaire Paul Tudor Jones' Top 10 Stock Picks
In this article we will take a look at billionaire Paul Tudor Jones' top 10 stocks picks.
Aimmune Therapeutics Inc. (AIMT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Syquant Capital Olivier Leymarie And Henri Jeantet | 0 | $0 | 0% | |
| 2. | Jasper Ridge Partners Mark Wolfson And Jamie Alexander | 0 | $0 | 0% | |
| 3. | Ancora Advisors Frederick Disanto | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Sculptor Capital Daniel S. Och | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $34.50 | 10,681,704 | Large Shareholder | 23,408,817 | 2020-10-13 | Filing | |
| $34.50 | 43,435,583 | Large Shareholder | 43,435,583 | 2020-10-13 | Filing | |
| $319.68 | 525,634 | Large Shareholder | 525,634 | 2020-02-07 | Filing | |
| $31.97 | 1,000,000 | Large Shareholder | 12,727,113 | 2020-02-07 | Filing | |
| $30.27 | 3,237,529 | Large Shareholder | 11,727,113 | 2018-11-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 7,840 | Director | 78,401 | 2020-05-27 | Filing | |
| $37.00 | 400 | Officer | 45,668 | 2020-01-16 | Filing | |
| $35.00 | 20,000 | Officer | 21,250 | 2020-01-02 | Filing | |
| $33.03 | 10,000 | Officer | 45,668 | 2019-12-26 | Filing | |
| $30.04 | 20,000 | Officer | 21,250 | 2019-12-09 | Filing |
Institutional Investors' Holdings
News See All
Billionaire Paul Tudor Jones' Top 5 Stock Picks
In this article we discuss the Billionaire Paul Tudor Jones' Top 5 Stock Picks.
Hedge Funds Are Dipping Their Toes Into Aimmune Therapeutics Inc (AIMT)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Aimmune Therapeutics Inc (AIMT): Did Hedge Funds Make The Right Call?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Are Buying Aimmune Therapeutics Inc (AIMT)
In this article you are going to find out whether hedge funds think Aimmune Therapeutics Inc (NASDAQ:AIMT) is a good investment right now.
Should You Avoid Aimmune Therapeutics Inc (AIMT)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW.
Hedge Fund and Insider Trading News: Seth Klarman, Bill Ackman, Ray Dalio, Citadel, Impala Asset Management, Aimmune Therapeutics Inc (AIMT), Nexstar Media Group Inc (NXST), and More
As the panic spurred by the coronavirus erases trillions from equity markets, whipsaws bonds and crushes energy prices, there may still be another shoe to drop.
Do Hedge Funds Love Aimmune Therapeutics Inc (AIMT) ?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Here is What Hedge Funds Think About Aimmune Therapeutics Inc (AIMT)
We at Insider Monkey have gone over 730 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of June...
Here's What Hedge Funds Think About Aimmune Therapeutics Inc (AIMT)
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund losing...